Detalles de la búsqueda
1.
Effect of sofosbuvir and velpatasvir therapy on clinical outcome in hepatitis C virus patients with decompensated cirrhosis.
Hepatol Res;
53(4): 301-311, 2023 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-36507871
2.
Comparison of atezolizumab plus bevacizumab and lenvatinib in terms of efficacy and safety as primary systemic chemotherapy for hepatocellular carcinoma.
Hepatol Res;
52(7): 630-640, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35417606
3.
Risk of hepatocellular carcinoma after sustained virologic response in hepatitis C virus patients without advanced liver fibrosis.
Hepatol Res;
52(10): 824-832, 2022 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-35749289
4.
Prognostic impact of worsening of esophageal varices after balloon-occluded retrograde transvenous obliteration.
J Gastroenterol Hepatol;
37(6): 1148-1155, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35430734
5.
Gab1 in livers with persistent hepatocyte apoptosis has an antiapoptotic effect and reduces chronic liver injury, fibrosis, and tumorigenesis.
Am J Physiol Gastrointest Liver Physiol;
320(6): G958-G968, 2021 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33787344
6.
Rubicon inhibits autophagy and accelerates hepatocyte apoptosis and lipid accumulation in nonalcoholic fatty liver disease in mice.
Hepatology;
64(6): 1994-2014, 2016 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-27637015
7.
[Chemoradiotherapy is effective for primary esophageal adenosquamous cell carcinoma but ineffective for the metastatic adenocarcinoma component].
Nihon Shokakibyo Gakkai Zasshi;
112(2): 278-86, 2015 Feb.
Artículo
en Japonés
| MEDLINE | ID: mdl-25748154
8.
Clinical factors associated with the therapeutic efficacy of atezolizumab plus bevacizumab in patients with unresectable hepatocellular carcinoma: A multicenter prospective observational study.
PLoS One;
19(1): e0294590, 2024.
Artículo
en Inglés
| MEDLINE | ID: mdl-38165900
9.
Postoperative bleeding after percutaneous transhepatic gallbladder drainage and aspiration in patients receiving antithrombotic therapy.
PLoS One;
18(8): e0288463, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37594942
10.
Thrombospondin-2 as a Predictive Biomarker for Hepatocellular Carcinoma after Hepatitis C Virus Elimination by Direct-Acting Antiviral.
Cancers (Basel);
15(2)2023 Jan 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-36672412
11.
Pretreatment with antibiotics is associated with reduced therapeutic response to atezolizumab plus bevacizumab in patients with hepatocellular carcinoma.
PLoS One;
18(2): e0281459, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36749777
12.
Posttreatment liver function, but not baseline liver function stratifies patient survival after direct-acting antiviral treatment in decompensated cirrhosis with hepatitis C virus.
J Gastroenterol;
58(12): 1211-1221, 2023 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37831182
13.
Incidence and risk factors of hepatocellular carcinoma in patients with hepatitis C who achieved a sustained virological response through direct-acting antiviral agents among the working population in Japan.
JGH Open;
6(6): 395-401, 2022 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-35774345
14.
Fucosylated haptoglobin is a novel predictive marker of hepatocellular carcinoma after hepatitis C virus elimination in patients with advanced liver fibrosis.
PLoS One;
17(12): e0279416, 2022.
Artículo
en Inglés
| MEDLINE | ID: mdl-36542633
15.
Interleukin-6 Is a Circulating Prognostic Biomarker for Hepatocellular Carcinoma Patients Treated with Combined Immunotherapy.
Cancers (Basel);
14(4)2022 Feb 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-35205631
16.
Circulating Cell-Free DNA Profiling Predicts the Therapeutic Outcome in Advanced Hepatocellular Carcinoma Patients Treated with Combination Immunotherapy.
Cancers (Basel);
14(14)2022 Jul 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35884434
17.
Persistent hepatocyte apoptosis promotes tumorigenesis from diethylnitrosamine-transformed hepatocytes through increased oxidative stress, independent of compensatory liver regeneration.
Sci Rep;
11(1): 3363, 2021 02 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33564095
18.
Hyperglycemia enhances pancreatic cancer progression accompanied by elevations in phosphorylated STAT3 and MYC levels.
PLoS One;
15(7): e0235573, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32609742
19.
DNase II activated by the mitochondrial apoptotic pathway regulates RIP1-dependent non-apoptotic hepatocyte death via the TLR9/IFN-ß signaling pathway.
Cell Death Differ;
26(3): 470-486, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29855540
20.
Development of a novel Borna disease virus reverse genetics system using RNA polymerase II promoter and SV40 nuclear import signal.
Microbes Infect;
8(6): 1522-9, 2006 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-16697679